Subject Matter Eligibility Retrospective: Informative PTAB Decisions Applying the 2019 Revised Guidance

March 30, 2020

It has long been recognized that, at a certain level, almost all patent claims include some abstract concepts. One of the hurdles facing practitioners and Examiners alike in determining subject matter eligibility under Section 101 has been drawing the line between claims that are “directed to” an abstract idea under the first step of the… Read more »

Author: Richard Hanna

Preparation, Diagnostics, Treatment… and Eligibility

March 30, 2020

In a recent subject matter eligibility case, the Federal Circuit reversed a district court decision finding that claims covering prenatal DNA testing were patent-ineligible. The Sequenom patents at issue, U.S. 9,580,751 (“the ‘751 patent”) and U.S. 9,738,931 (“the ‘931 patent”), are directed to a method for preparing a DNA fraction from a pregnant human female… Read more »

Disavowal of Claim Scope in Techtronic Industries co. v. ITC: Federal Circuit Ties Patent to the Described “Invention” and the Problem being Solved

January 15, 2020

In an opinion focused on claim construction and disavowal, the Federal Circuit in Techtronic Industries co. v. ITC found that a patent’s repeated discussion and focus on providing a passive infrared detector disavowed any products that lack a passive infrared detector.1 The patent at issue (U.S. Patent No. 7,161,319, or ‘319 patent) relates to “movable barrier operators”… Read more »

The “Validity Goulash” of American Axle

November 04, 2019

In American Axle & Manufacturing v. Neapco Holdings1, the Federal Circuit was tasked with determining whether claims directed to a method of manufacturing that utilize at least one, and possible other, natural laws, are eligible for patenting under 35 U.S.C. § 101. As detailed in the dissent by Judge Moore, the Federal Circuit appears to do… Read more »

The Federal Circuit Flexes Its Muscle in Cleveland Clinic (But Not the One it Should Have)

April 08, 2019

In our January Blog Post related to the January 2019 USPTO Subject Matter Eligibility Guidance (“the Guidance”), and our subsequent Blog Post in February , we noted that it was unclear how the courts will view issued personalized medicine claims examined under the Guidance, as it appeared that the USPTO may want to push the courts to reexamine the… Read more »

Does USPTO Subject Matter Eligibility Guidance Muddy the Personalized Medicine Waters?

January 22, 2019

The USPTO’s recently revised guidance for determining subject matter eligibility under 35 U.S.C. § 101 (“the Guidance”),1 provides some clarity to Examiners and Applicants as to what constitutes an “abstract idea.” While the Guidance identifies several abstract ideas that fall within the scope of a “Judicial Exception” during Prong One of the Alice/Mayo test (Step 2A of the… Read more »

Let's Get Started

Tel: (703) 712-8531

Address
Medler Ferro Woodhouse & Mills PLLC
8201 Greensboro Drive, Suite 1060
McLean, VA 22102

Phone and Fax
tel: (703) 712-8531
fax: (703) 712-8525